Dr. Haibo  Xu
My Social Links

Dr. Haibo Xu

Professor
Chinese Materia Medica, China


Highest Degree
PostDoc. in Clinical Pharmacy and Toxicology from University of Bristol, UK

Share this Profile



Advertisement
Event

Area of Interest:

Pharmacology and Toxicology
100%
Pharmacy
62%
Molecular Biology
90%
Immunology
75%
Surgery
55%

Research Publications in Numbers

Books
0
Chapters
0
Articles
0
Abstracts
0

Selected Publications

  1. Wan, S., L. Tan, N. Lei, Y. Shi and M. He et al., 2018. Compound bieshe kangai inhibits proliferation and induces apoptosis in HCT116 human colorectal cancer cells. Trop. J. Pharm. Res., 17: 2163-2168.
    CrossRef  |  Direct Link  |  
  2. Xu, H., 2017. Factors that Influence The Effects of Chinese Materia Medica. In: Pharmacology of Chinese Materia Medica, Chang-xun, C., (Ed.). China Press, China, pp: 23-31.
  3. Jin-hao, Z., P. Hua-feng, L. You-zhang, X. Hai-bo and Z. Zi-ming er al., 2016. Effects of Weipixiao on Wnt pathway-associated proteins in gastric mucosal epithelial cells from rats with gastric precancerous lesions. Chin. J. Integrat. Med., 22: 267-275.
  4. Xu, H., D. Wang, C. Peng, X. Huang and M. Ou et al., 2014. Rabbit sera containing compound danshen dripping pill attenuate leukocytes adhesion to TNF-alpha–activated human umbilical vein endothelial cells by suppressing endothelial ICAM-1 and VCAM-1 expression through NF-kappaB signaling pathway. J. Cardiovasc. Pharmacol., 63: 323-332.
    CrossRef  |  Direct Link  |  
  5. Xu, H., Q. Wu, C. Peng and L. Zhou, 2013. Study on the antiviral activity of San Huang Yi Gan Capsule against hepatitis B virus with seropharmacological method. BMC Complem. Altern. Med., Vol.13. .
    Direct Link  |  
  6. Xu, H., E.B. Oliveira-Sales, F. McBride, B. Liu and J. Hewinson et al., 2012. Upregulation of junctional adhesion molecule-A is a putative prognostic marker of hypertension. Cardiovascular Res., 96: 552-560.
    CrossRef  |  Direct Link  |  
  7. Cao, Y., X. Liu and H. Xu, 2012. Utility of serum tartrate-resistant acid phosphatase isoform 5b, bone alkaline phosphatase and osteocalcin in osteoporotic fractures in Chinese patients. Clin. Laborat., 58: 845-850.
    Direct Link  |  
  8. Liu, B., J. Hewinson, H. Xu, F. Montero and C.R. Sunico et al., 2011. NOS Antagonism Using Viral Vectors as an Experimental Strategy: Implications for in vivo Studies of Cardiovascular Control and Peripheral Neuropathies. In: Nitric Oxide: Methods and Protocols (Methods in Molecular Biology), McCarthy, H. and J. Coulter, (Eds.). Humana Press, New York, ISBN: 978-1-61737-963-5, pp: 197-223.
  9. Xu, H., G.H. Posner, M. Stevenson and F.C. Campbell, 2010. Apc MIN modulation of vitamin D secosteroid growth control. Carcinogenesis, 31: 1434-1441.
    CrossRef  |  Direct Link  |  
  10. Liu, B., H. Xu, J.F.R. Paton and S. Kasparov, 2010. Cell- and region-specific miR30-based gene knock-down with temporal control in the rat brain. BMC Mol. Biol., 11: 93-103.
  11. Campbell, F.C., H. Xu, M. El-Tanani, P. Crowe and V. Bingham, 2010. The yin and yang of vitamin D receptor (VDR) signaling in neoplastic progression: Operational networks and tissue-specific growth control. Biochem. Pharmacol., 79 : 1-9.
    CrossRef  |  Direct Link  |  
  12. Xu, H., M. Toward, J.F.R. Paton and S. Kasparov, 2009. Over expressed junctional adhesion molecule-1 is implicated in angiotensin-II induced-hypertension. J. Hypertens, 27: S17-S18.
  13. Xu, H., M. McCann, Z. Zhang, G.H. Posner, V. Bingham, M. El-Tanani and F.C. Campbell, 2009. Vitamin D receptor modulates the neoplastic phenotype through antagonistic growth regulatory signals. Mol. Carcinog., 4: 758-772.
    CrossRef  |  Direct Link  |  
  14. Chen, X., H. Xu, C. Wan, M.M. Caigue and G. Li, 2006. Bioreactor expansion of human adult bone marrow‐derived mesenchymal stem cells. Stem Cells, 24: 2052-2059.
    CrossRef  |  Direct Link  |  
  15. Chen, X., H. Xu, C. Wan and G. Li, 2006. Expansion of mesenchymal stem cells in 3-D bioreactor system. Orthop. Proc., 88: 402-402.
  16. Xu, H. and M. El-Tanani, 2005. Frederick charles campbell. nuclear vitamin D receptor regulation of OPN/TCF4/beta-catenin signalling. Eur. J. Cancer., S3: 58-58.